Finance

Lists
VICO:STO
Vicore Pharma Holding AB
SEK 10.44
-1.69%
(-0.18) 1D
Nov 17, 10:03:00 AM GMT+1  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for VICO...
Open
SEK 10.54
High
SEK 10.58
Low
SEK 10.42
Mkt. cap
2.94B
Avg. vol.
1.59M
Volume
196.65K
52-wk high
SEK 18.24
52-wk low
SEK 8.56
EPS
-SEK 1.87
Shares outstanding
281.64M
No. of employees
50
Open
SEK 10.54
High
SEK 10.58
Low
SEK 10.42
Mkt. cap
2.94B
Avg. vol.
1.59M
Volume
196.65K
52-wk high
SEK 18.24
52-wk low
SEK 8.56
EPS
-SEK 1.87
Shares outstanding
281.64M
No. of employees
50
News stories
From web sources and news partners
About Vicore Pharma Holding AB
CEO-
Employees50
Founded2000
Headquarters-
SectorHealth Care
IndustryBiotechnology
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
419.00K
602.00K
2.21M
594.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
113.04M
102.60M
126.74M
107.28M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22.06M
21.51M
37.05M
26.43M
Operating expense
135.10M
124.11M
163.79M
133.71M
Total operating expenses
135.10M
124.11M
163.79M
133.71M
Operating income
-134.68M
-123.50M
-161.57M
-133.11M
Other non operating income
-
-
1.00K
-1.00K
EBT including unusual items
-137.10M
-108.53M
-154.32M
-124.28M
EBT excluding unusual items
-137.10M
-108.53M
-154.32M
-124.28M
Income tax expense
-
86.00K
174.00K
-
Effective tax rate
-
-0.08%
-0.11%
-
Other operating expenses
-
-
-
-
Net income
-137.10M
-108.62M
-154.49M
-124.28M
Net profit margin
-32,721.48%
-18,042.52%
-6,980.98%
-20,922.22%
Earnings per share
-0.54
-0.39
-0.51
-0.44
Interest and investment income
45.52M
15.96M
7.28M
8.99M
Interest expense
-
-643.00K
-
-
Net interest expenses
45.52M
15.32M
7.28M
8.99M
Depreciation and amortization charges
-
-
-
-
EBITDA
-134.12M
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps